Mario Negri Institute For Pharmacological Research

This study tested whether adding a drug called ATRA to standard hormone therapy (anastrozole) could better shrink early-stage breast tumors before surgery. It involved 76 postmenopausal women with a specific type of breast cancer (HR-positive/HER2-negative). The goal was to see i…

This study tested a three-step treatment for patients with a large, inoperable form of lung cancer who cannot receive the standard therapy. The goal was to see if starting with a drug called durvalumab plus chemotherapy could shrink tumors enough for patients to safely receive fo…